Aeon Global Health Corp. (AGHC) financial statements (2022 and earlier)
Company profile
| Business Address |
2225 CENTENNIAL DRIVE GAINESVILLE, 30504 |
| State of Incorp. | DE |
| Fiscal Year End | June 30 |
| SIC | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 1 | 1 | 1 | 1 | 0 | 1 | ||
| Cash and cash equivalents | 1 | 1 | 1 | 1 | 0 | 1 | ||
| Short-term investments | 0 | |||||||
| Restricted cash and investments | 0 | 0 | 0 | 0 | ||||
| Receivables | 2 | 3 | 1 | 2 | 0 | 1 | ||
| Inventory, net of allowances, customer advances and progress billings | 1 | 0 | 0 | 0 | 1 | 3 | ||
| Inventory | 1 | 0 | 0 | 0 | 1 | 3 | ||
| Other undisclosed current assets | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total current assets: | 3 | 4 | 3 | 4 | 2 | 5 | ||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 1 | 1 | 2 | 3 | 0 | 0 | ||
| Intangible assets, net (including goodwill) | 6 | 4 | 4 | |||||
| Goodwill | 3 | 0 | 0 | |||||
| Intangible assets, net (excluding goodwill) | 2 | 4 | 4 | |||||
| Deposits noncurrent assets | 0 | 0 | ||||||
| Other noncurrent assets | 0 | 1 | ||||||
| Deferred tax assets, net | 6 | 12 | 38 | |||||
| Other undisclosed noncurrent assets | (2) | (2) | ||||||
| Total noncurrent assets: | 1 | 7 | 14 | 47 | 3 | 3 | ||
| TOTAL ASSETS: | 4 | 11 | 17 | 52 | 4 | 8 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 5 | 5 | 5 | 6 | 2 | 3 | ||
| Accounts payable | 2 | 1 | 2 | 4 | 1 | |||
| Accrued liabilities | 3 | 2 | 2 | 2 | 1 | |||
| Taxes payable | 0 | 1 | ||||||
| Interest and dividends payable | 0 | 1 | 1 | |||||
| Other undisclosed accounts payable and accrued liabilities | 0 | 3 | ||||||
| Debt | 3 | 3 | 2 | |||||
| Deferred rent credit | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Derivative instruments and hedges, liabilities | 0 | 1 | 1 | |||||
| Due to related parties | 2 | 3 | ||||||
| Deferred revenue and credits | ✕ | 0 | 0 | 0 | ||||
| Other undisclosed current liabilities | 1 | 1 | 0 | 2 | 0 | |||
| Total current liabilities: | 8 | 10 | 9 | 12 | 5 | 3 | ||
| Noncurrent Liabilities | ||||||||
| Liabilities, other than long-term debt | 2 | 0 | 0 | 0 | 0 | 0 | ||
| Deferred revenue and credits | ✕ | 0 | 0 | 0 | 0 | |||
| Deferred rent credit | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ||
| Due to related parties | 1 | |||||||
| Total noncurrent liabilities: | 2 | 0 | 0 | 0 | 0 | 0 | ||
| Total liabilities: | 10 | 10 | 9 | 12 | 5 | 3 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | (6) | 0 | 8 | 40 | (0) | 5 | ||
| Preferred stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 48 | 45 | 44 | 38 | 206 | 201 | ||
| Retained earnings (accumulated deficit) | (54) | (45) | (36) | 2 | (206) | (196) | ||
| Total stockholders' equity: | (6) | 0 | 8 | 40 | (0) | 5 | ||
| TOTAL LIABILITIES AND EQUITY: | 4 | 11 | 17 | 52 | 4 | 8 | ||
Income statement (P&L) ($ in millions)
| 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 13 | 16 | 20 | 35 | 4 | 6 | |
| Revenue, net | ✕ | 20 | 35 | 4 | 6 | ||
| Cost of revenue | (5) | (4) | (4) | (7) | (2) | (4) | |
| Gross profit: | 8 | 12 | 16 | 28 | 2 | 2 | |
| Operating expenses | (10) | (12) | (16) | (11) | (13) | ||
| Other undisclosed operating income (loss) | (0) | (1) | (5) | (22) | 0 | 4 | |
| Operating income (loss): | (3) | (1) | (5) | 6 | (9) | (7) | |
| Nonoperating income (expense) | 0 | (1) | (0) | (0) | (1) | (0) | |
| Investment income, nonoperating | 1 | (1) | 1 | ||||
| Other nonoperating expense | (0) | (0) | (0) | (0) | |||
| Interest and debt expense | (0) | (0) | (0) | (1) | (0) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (3) | (2) | (6) | 5 | (10) | (7) | |
| Other undisclosed income from continuing operations before income taxes | 0 | 0 | 0 | ||||
| Income (loss) from continuing operations before income taxes: | (3) | (2) | (5) | 6 | (10) | (7) | |
| Income tax expense | (5) | (6) | (27) | (0) | |||
| Net income (loss): | (8) | (8) | (32) | 5 | (10) | (7) | |
| Other undisclosed net income attributable to parent | 1 | 0 | |||||
| Net income (loss) attributable to parent: | (8) | (8) | (32) | 5 | (10) | (7) | |
| Preferred stock dividends and other adjustments | (0) | (0) | (0) | (0) | |||
| Other undisclosed net loss available to common stockholders, basic | (0) | (2) | |||||
| Net income (loss) available to common stockholders, basic: | (8) | (8) | (32) | 5 | (10) | (10) | |
| Interest on convertible debt | 0 | ||||||
| Convertible preferred dividends | 0 | ||||||
| Net income (loss) available to common stockholders, diluted: | (8) | (8) | (32) | 5 | (10) | (10) | |
Comprehensive Income ($ in millions)
| 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (8) | (8) | (32) | 5 | (10) | (7) | |
| Comprehensive income (loss): | (8) | (8) | (32) | 5 | (10) | (7) | |
| Other undisclosed comprehensive income, net of tax, attributable to parent | 1 | 0 | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | (8) | (8) | (32) | 5 | (10) | (7) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.